Effect of chronic mild stress and imipramine on the proteome of the rat dentate gyrus

Journal of Neurochemistry

Volumn 113, Issue 4, 2010, Pages 848-859

  Kedracka Krok, Sylwia ^a   Fic, Ewelina ^a   Jankowska, Urszula ^a   Jaciuk, Marcin ^a   Gruca, Piotr ^b   Papp, Mariusz ^b   Kusmider, MacIej ^b   Solich, Joanna ^b   Debski, Janusz ^c   Dadlez, Michal ^c   Dziedzicka Wasylewska, Marta ^a,b  

^a JAGIELLONIAN UNIVERSITY   (Poland)

^b INSTITUTE OF PHARMACOLOGY   (Poland)

^c INSTITUTE OF BIOCHEMISTRY AND BIOPHYSICS   (Poland)

Author keywords

Chronic mild stress; Hippocampus; Imipramine; Proteomics

Indexed keywords

ALPHA ENOLASE; BRAIN PROTEIN; DYNACTIN; DYNACTIN 2; IMIPRAMINE; PROTEIN ASH2; PROTEIN SNAP25; PROTEOME; SUCROSE; UNCLASSIFIED DRUG;

AMINO ACID SEQUENCE; ANHEDONIA; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CHRONIC STRESS; CONTROLLED STUDY; DENTATE GYRUS; HIPPOCAMPUS; MALE; MASS SPECTROMETRY; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEOMICS; RAT; TWO DIMENSIONAL ELECTROPHORESIS; WESTERN BLOTTING;

ANIMALS; ANTIDEPRESSIVE AGENTS, TRICYCLIC; APPETITE; CHRONIC DISEASE; DENTATE GYRUS; DEPRESSIVE DISORDER; DISEASE MODELS, ANIMAL; DNA-BINDING PROTEINS; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; FEEDING BEHAVIOR; IMIPRAMINE; MALE; MASS SPECTROMETRY; MICROTUBULE-ASSOCIATED PROTEINS; NERVE TISSUE PROTEINS; NUCLEAR PROTEINS; PHOSPHOPYRUVATE HYDRATASE; PROTEOME; RATS; RATS, WISTAR; STRESS, PSYCHOLOGICAL; SYNAPTOSOMAL-ASSOCIATED PROTEIN 25; TRANSCRIPTION FACTORS;

ANIMALIA; RATTUS;

EID: 77950943420     PISSN: 00223042     EISSN: 14714159     Source Type: Journal    
DOI: 10.1111/j.1471-4159.2010.06652.x     Document Type: Article

References (70)

1. Abe T. K., Tanaka H., Iwanaga T. et al. (1997) The presence of the 50-kDa subunit of dynactin complex in the nerve growth cone. Biochem. Biophys. Res. Commun. 233, 295 299.
2. Aebersold R. Mann M. (2003) Mass spectrometry-based proteomics. Nature 422, 198 207.
3. Antelman S. M. Gershon S. (1998) Clinical application of time-dependent sensitization to antidepressant therapy. Prog. Neuro-Psychopharmacol. Biol. Psychiat. 22, 65 78.
4. Antelman S. M., Levine J. Gershon S. (2000) Time-dependent sensitization: the odyssey of a scientific heresy from the laboratory to the door of the clinic. Mol. Psychiatry 5, 350 356.
5. Aoyagi M., Arvai A. S., Tainer J. A. et al. (2003) Structural basis for endothelial nitric oxide synthase binding to calmodulin. EMBO J. 4, 766 775.
6. Bisgaard C. F., Jayatissa M. N., Enghild J. J. et al. (2007) Proteomic investigation of the ventral rat hippocampus links DRP-2 to escitalopram treatment resistance and SNAP to stress resilience in the chronic mild stress model of depression. J. Mol. Neurosci. 32, 132 144.
7. Bogen I. L., Boulland J. L., Mariussen E. et al. (2006) Absence of synapsin I and II is accompanied by decreases in vesicular transport of specific neurotransmitters. J. Neurochem. 96, 1458 1466.
8. Bradford M. M. (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72, 248 254.
9. Campbell S. Macqueen G. (2004) The role of the hippocampus in the pathophysiology of major depression. J. Psychiatry Neurosci. 29, 417 426.
10. Canossa M., Giordano E., Cappello S. et al. (2002) Nitric oxide down-regulates brain-derived neurotrophic factor secretion in cultured hippocampal neurons. Proc. Natl Acad. Sci. USA 99, 3282 3287.
11. Carboni L., Vighini M., Piubelli C. et al. (2006a) Proteomic analysis of rat hippocampus and frontal cortex after chronic treatment with fluoxetine or putative novel antidepressants: CRF1 and NK1 receptor antagonists. Eur. Neuropsychopharmacol. 16, 521 537.
12. Carboni L., Piubelli C., Pozzato C. et al. (2006b) Proteomic analysis of rat hippocampus after repeated psychosocial stress. Neuroscience 137, 1237 1246.
13. Castegna A., Thongboonkerd V., Klein J. B. et al. (2003) Proteomic identification of nitrated proteins in Alzheimer's disease brain. J. Neurochem. 85, 1394 1401.
14. Chen J., Zacharek A., Zhang C. et al. (2005) Endothelial nitric oxide synthase regulates Brain-derived neurotrophic factor expression and neurogenesis after stroke in mice. J. Neurosci. 25, 2366 2375.
15. Chen W. Q., Viidik A., Skalicky M. et al. (2007) Hippocampal signaling cascades are modulated in voluntary and treadmill exercise rats. Electrophoresis 28, 4392 4400.
16. Cheng A., Wang S., Cai J. et al. (2003) Nitric oxide acts in a positive feedback loop with BDNF to regulate neural progenitor cell proliferation and differentiation in the mammalian brain. Dev. Biol. 258, 319 333.
17. Chiodo L. A. Antelman S. M. (1980) Electroconvulsive shock: progressive dopamine autoreceptor subsensitivity independent of repeated treatment. Science 210, 799 801.
18. Deacon S. W., Serpinskaya A. S., Vaughan P. S. et al. (2003) Dynactin is required for bidirectional organelle transport. J. Cell Biol. 160, 297 301.
19. Deuschle M., Schmider J., Weber B. et al. (1997) Pulse-dosing and conventional application of doxepin: effects on psychopathology and hypothalamus-pituitary-adrenal (HPA) system. J. Clin. Psychopharmacol. 17, 156 160.
20. Drigues N., Poltyrev T., Bejar C. et al. (2003) cDNA gene expression profile of rat hippocampus after chronic treatment with antidepressant drugs. J. Neural Transm. 110, 1413 1436.
21. D'Sa C. Duman R. S. (2002) Antidepressants and neuroplasticity. Bipolar Disord. 4, 183 194.
22. Dube S., Perel J. M., Miewald J. et al. (1996) Antidepressant response to oral pulse loading with clomipramine. Biol. Psychiatry 39, 623 640.
23. Dziedzicka-Wasylewska M. Rogoz Z. (1997) Time-dependent effects of antidepressant drugs on the low dose of apomorphine-induced locomotor hypoactivity in rats. Pol. J. Pharmacol. 49, 337 343.
24. Dziedzicka-Wasylewska M. Rogoz R. (1999) Effects of antidepressant drugs on the dopamine D2/D3 receptors in the rat brain differentiated by agonist and antagonist binding - an autoradiographic analysis. Naunyn Schmiedebergs Arch. Pharmacol. 359, 178 186.
25. Fountoulakis M. Kossida S. (2006) Proteomics-driven progress in neurodegeneration research. Electrophoresis 27, 1556 1573.
26. Frodl T., Schaub A., Banac S. et al. (2006) Reduced hippocampal volume correlates with executive dysfunctioning in major depression. J. Psychiatry Neurosci. 31, 316 323.
27. Griffin T. J. Aebersold R. (2001) Advances in proteome analysis by mass spectrometry. J. Biol. Chem. 276, 45497 45500.
28. Hagens O., Minina E., Schweiger S. et al. (2006) Characterization of FBX25, encoding a novel brain-expressed F-box protein. Biochim. Biophys. Acta 1760, 110 118.
29. Jagadeesh H. N., Gangadhar B. N., Janakiramaiah N. et al. (1992) Time dependent therapeutic effects of single electroconvulsive therapy (ECT) in endogenous depression. J. Affect. Disord. 24, 291 295.
30. Jayatissa M. N., Bisgaard C., Tingström A. et al. (2006) Hippocampal cytogenesis correlates to escitalopram-mediated recovery in a chronic mild stress rat model of depression. Neuropsychopharmacology 31, 2395 2404.
31. Jayatissa M. N., Bisgaard C. F., West M. J. et al. (2008) The number of granule cells in rat hippocampus is reduced after chronic mild stress and re-established after chronic escitalopram treatment. Neuropharmacology 54, 530 541.
32. Johnston-Wilson N. L., Sims C. D., Hofmann J. P. et al. (2000) Disease-specific alterations in frontal cortex brain proteins in schizophrenia, bipolar disorder, and major depressive disorder. Mol. Psychiatry 5, 142 149.
33. Khawaja X., Xu J., Liang J. J. et al. (2004) Proteomic analysis of protein changes developing in rat hippocampus after chronic antidepressant treatment: Implications for depressive disorders and future therapies. J. Neurosci. Res. 75, 451 460.
34. Kim J. J. Yoon K. S. (1998) Stress: metaplastic effects in the hippocampus. Trends Neurosci. 21, 505 509.
35. Kim S. S., Pandey K. K., Choi H. S. et al. (2005) Poly(C) binding protein family is a transcription factor in mu-opioid receptor gene expression. Mol. Pharmacol. 68, 729 736.
36. Kipreos E. T. Pagano M. (2000) The F-box protein family. Genome Biol. 1, 30021 30027.
37. de Kloet E. R., Joëls M. Holsboer F. (2005) Stress and the brain: from adaptation to disease. Nat. Rev. Neurosci. 6, 463 475.
38. Kulig E. (1991) Biochemical characteristics of gamma enolase isoenzyme and its diagnostic significance. Postepy Biochem. 37, 112 120.
39. Kusmider M., Faron-Gorecka A. Dziedzicka-Wasylewska M. (2006) Delayed effects of antidepressant drugs in rats. Behav. Pharmacol. 17, 641 649.
40. Makeyev A. V. Liebhaber S. A. (2002) The poly(C)-binding proteins: a multiplicity of functions and a search for mechanisms. RNA 8, 265 278.
41. Malberg J. E. Blendy J. A. (2005) Antidepressant action: to the nucleus and beyond. Trends Pharmacol. Sci. 26, 631 638.
42. Malhotra S. Santosh P. J. (1996) Loading dose imipramine-new approach to pharmacotherapy of melancholic depression. J. Psychiatr. Res. 30, 51 58.
43. Mann M., Højrup P. Roepstorff P. (1993) Use of mass spectrometric molecular weight information to identify proteins in sequence database. Biol. Mass Spectrom. 22, 338 345.
44. McPherson P. S., Czernik A. J., Chilcote T. J. et al. (1994) Interaction of Grb2 via its Src homology 3 domains with synaptic proteins including synapsin I. Proc. Natl Acad. Sci. USA 91, 6486 6490.
45. Miura K., Miki H., Shimazaki K. et al. (1996) Interaction of Ash/Grb-2 via its SH3 domains with neuron-specific p150 and p65. Biochem. J. 316, 639 645.
46. Mu J., Xie P., Yang Z. S. et al. (2007) Neurogenesis and major depression: implications from proteomic analyses of hippocampal proteins in a rat depression model. Neurosci. Lett. 416, 252 256.
47. O'Farrell P. H. (1975) High resolution two-dimensional electrophoresis of proteins. J. Biol. Chem. 250, 4007 4021.
48. Paulson L., Martin P., Persson A. et al. (2003) Comparative genome- and proteome analysis of cerebral cortex from MK-801-treated rats. J. Neurosci. Res. 71, 526 533.
49. Pollock B. G., Perel J. M., Shostak M. et al. (1986) Understanding the response lag to tricyclics. I. Application of pulse-loading regimens with intravenous clomipramine. Psychopharmacol. Bull. 22, 214 219.
50. Pollock B. G., Perel J. M., Nathan R. S. et al. (1989) Acute antidepressant effect following pulse loading with intravenous and oral clomipramine. Arch. Gen. Psychiatry 46, 29 35.
51. Sallee F. R., Vrindavanam N. S., Deas-Nesmith D. et al. (1997) Pulse intravenous clomipramine for depressed adolescents: double-blind, controlled trial. Am. J. Psychiatry 154, 668 673.
52. Satoh K., Takeuchi M., Oda Y. et al. (2002) Identification of activity-regulated proteins in the postsynaptic density fraction. Genes Cells 7, 187 197.
53. Sharma H. S., Nyberg F., Westman J. et al. (1998) Brain derived neurotrophic factor and insulin like growth factor-1 attenuate upregulation of nitric oxide synthase and cell injury following trauma to the spinal cord. An immunohistochemical study in the rat. Amino Acids 14, 121 129.
54. Surendran S., Tyring S. K. Matalon R. (2005) Expression of calpastatin, minopontin, NIPSNAP1, rabaptin-5 and neuronatin in the phenylketonuria (PKU) mouse brain: possible role on cognitive defect seen in PKU. Neurochem. Int. 46, 595 599.
55. Surget A., Saxe M., Leman S. et al. (2008) Drug-dependent requirement of hippocampal neurogenesis in a model of depression and of antidepressant reversal. Biol. Psychiatry 64, 293 301.
56. Tilleman K., Van den Haute C., Geerts H. et al. (2002) Proteomics analysis of the neurodegeneration in the brain of tau transgenic mice. Proteomics 2, 656 665.
57. Tohda M., Qi Z. Watanabe H. (1999) Influence of chronic treatment with imipramine on mRNA levels in rat brain: elevation of glyceraldehyde-3-phosphate dehydrogenase levels. Jpn. J. Pharmacol. 81, 393 396.
58. Tsakiris S., Marinou K. Schulpis K. H. (2002) The effect of galactose metabolic disorders on rat brain Na+,K+-ATPase activity. Z. Naturforsch. 57, 939 943.
59. Vaidya V. A. Duman R. S. (2001) Depression-emerging insights from neurobiology. Br. Med. Bull. 57, 61 79.
60. Villanueva M., Thornley K., Augustine G. J. et al. (2006) Synapsin II negatively regulates catecholamine release. Brain Cell Biol. 35, 125 136.
61. Watanabe K., Fukuchi T., Hosoya H. et al. (1995) Splicing isoforms of rat Ash/Grb2. isolation and characterization of the cDNA and genomic DNA clones and implications for the physiological roles of the isoforms. Am. Soc. Biochem. Mol. Biol. 270, 13733 13739.
62. Weitzdörfer R., Höger H., Shim K. S. et al. (2008) Changes of hippocampal signaling protein levels during postnatal brain development in the rat. Hippocampus 18, 807 813.
63. Willner P. (1997) Validity, reliability and utility of the chronic mild stress model of depression: a 10-year review and evaluation (Review). Psychopharmacology 134, 319 329.
64. Willner P. (2005) Chronic mild stress (CMS) revisited: consistency and behavioural-neurobiological concordance in the effects of CMS (Review). Neuropsychobiology 52, 90 110.
65. Willner P., Towell A., Sampson D. et al. (1987) Reduction of sucrose preference by chronic unpredictable mild stress, and its restoration by a tricyclic antidepressant. Psychopharmacology 93, 358 364.
66. Witzmann F. A., Arnold R. J., Bai F. et al. (2005) A proteomic survey of rat cerebral cortical synaptosomes. Proteomics 5, 2177 2201.
67. Wu J., Wang F., Gong Y. et al. (2009) Proteomic analysis of changes induced by nonylphenol in sprague-dawley rat sertoli cells. Chem. Res. Toxicol. 22, 668 675.
68. Yan J. X., Wait R., Berkelman T. et al. (2000) A modified silver staining protocol for visualization of proteins compatible with matrix-assisted laser desorption/ionization and electrospray ionization-mass spectrometry. Electrophoresis 21, 3666 3672.
69. Yang J. W., Juranville J. F., Höger H. et al. (2005) Molecular diversity of rat proteins as revealed by proteomic analysis. Mol. Divers. 9, 385 396.
70. Yildiz A., Gonul A. S. Tamam L. (2002) Mechanism of actions of antidepressants: beyond the receptors. Bull. Clin. Psychopharmacol. 12, 194 200.